Brain-nourishing molecule may predict schizophrenia relapse

A factor that helps optimize brain formation and function may also provide clues about whether patients suffering with schizophrenia are headed toward relapse, researchers say.

Over the next two- and one-half years, they are regularly measuring levels of brain-derived neurotrophic factor, or BDNF, in the blood of patients with schizophrenia to see if the pattern of their rise and fall is a good indicator that patients are headed for trouble, say Medical College of Georgia researchers.

"If you had something that would give you a better inkling that somebody is going to get ill, that would be extraordinarily helpful," says Dr. Peter S. Buckley, schizophrenia specialist who chairs the Department of Psychiatry and Health Behavior in the MCG School of Medicine. "It's a little bit of a shot in the dark, but the payoff would be huge," he says of the study that piggybacks on another federally-funded study looking at whether injectable medicine, rather than tablets, can help deter relapses.

Not taking their medicines as prescribed is a big reason patients relapse but science has already shown that BDNF levels can start dropping even when they do, says Dr. Anilkumar R. Pillai, MCG neuroscientist who studies BDNF and other cell-nourishing trophic factors. That drop likely indicates the drug is becoming less effective and a relapse is imminent, the researchers say.

Decreased BDNF levels already have been associated with relapsing bipolar disease and depression, Dr. Buckley says. Dr. Pillai and others have shown that the BDNF levels in patients with schizophrenia are generally lower than in healthy individuals, an indicator of its importance in this disease, he says. BDNF levels may be even lower in patients when they relapse and go up, at least for a while, with treatment.

"Theoretically, at least, if you could know the point when BDNF levels start going down, you might change the treatment…that's at least one approach for the future, if the study results point in that direction," says Dr. Pillai. He also studies an animal model that has many behavioral as well as neurochemical abnormalities similar to schizophrenia. He's shown the downstream signaling of BDNF, a key pathway in the regulation of the inhibitory neurotransmitter GABA, is not working well in these animals. "Now we are going to see how we can rectify the problem," says Dr. Pillai who wants to keep BDNF levels on a more even keel.

About a dozen older schizophrenia medications and a handful of new ones adjust the activity level of a variety of neurotransmitters in the brain, Dr. Pillai says. Animal studies have shown the drugs have a differing impact on BDNF as well. Most initially improve the level then, with time, levels decrease of this factor that is required for brain development as well as cell proliferation, migration, differentiation and survival.

In the normal adult brain, BDNF increases stem cell proliferation so the brain is better armed if something bad, like a stroke, happens. Trophic factors such as BDNF also induce anti-apoptotic mechanisms that keep cells from committing suicide when stressed by a lack of oxygen, for example. Exactly where BDNF comes from or what controls endogenous levels is still unclear. Exercise can increase BDNF levels. Two drugs currently on the market for other medical conditions – erythropoietin for anemia and cysteamine for cystinosis – can as well. Dr. Pillai hopes his laboratory studies of these drugs will soon result in an adjunct therapy that can help patients avoid devastating relapse. "Our aim is to bring BDNF levels back to normal." Dr. Pillai and colleagues already have shown in their animal studies that antipsychotic drugs do better boosting brain BDNF levels when administered along with any of the above drugs. He adds that both cysteamine and erythropoietin have been well studied for their potential to enhance cognitive function.

Schizophrenia affects about 1 percent of the population or some 2.4 million American adults. Hallucinations are a disease hallmark; patients hear voices and can even see, touch and taste things that are not real. Patients, when they relapse, can become aggressive, reclusive and suicidal. Dr. Buckley notes that even when patients are followed closely – every two weeks as they are in these studies – relapse occurs.

Today there is no objective way or "test" to diagnose schizophrenia, measure efficacy of treatment or predict the common problem of relapse, Dr. Buckley says. "We are looking for how to predict things in mental illness: could you predict whether somebody will get along well or not, could you predict whether a treatment will work, could you predict side effects?"

Source: Medical College of Georgia

Related stories:

Low levels of brain chemical may lead to obesity
A brain chemical that plays a role in long term memory also appears to be involved in regulating how much people eat and their likelihood of becoming obese, according to a National Institutes of Health study of a rare genetic condition.
Scientists learn how food affects the brain
In addition to helping protect us from heart disease and cancer, a balanced diet and regular exercise can also protect the brain and ward off mental disorders.
Mice offer clues to the roots of human resilience
When faced with adversity, some people succumb to debilitating psychological diseases including posttraumatic stress disorder and depression, while others are able to remain remarkably optimistic.
Exercise increases brain growth factor and receptors, prevents stem cell drop in middle age
A new study confirms that exercise can reverse the age-related decline in the production of neural stem cells in the hippocampus of the mouse brain, and suggests that this happens because exercise restores a brain chemical which promotes the production and maturation of new stem cells.
The mental health dangers of birth hypoxia
Complications during pregnancy and birth, such as birth hypoxia - the shortage of oxygen in the body - are associated with an increased risk for schizophrenia. However, it is not clear why hypoxia increases the risk for schizophrenia. The November 1st issue of Biological Psychiatry includes an article by researchers who show that the presence of a specific indicator of fetal distress following hypoxia was more likely to be present among people who later develop schizophrenia. Their findings suggest that the inability of a high-risk fetus to respond adequately to metabolic stresses that it faces in the womb may contribute to its later risk for developing schizophrenia.
A new relationship between brain derived neurotrophic factor and inflammatory signaling
In the October 14th edition of Science Signaling researchers at Boston University School of Medicine (BUSM), The Children's Hospital of Philadelphia/University of Pennsylvania School of Medicine and The University of Colorado Denver School of Medicine have shown that the development of epilepsy in adult rats is linked to functional changes in the expression of alpha 1 containing GABA-A receptors, the main inhibitory neurotransmitter receptor in the brain, that may be dependent upon BDNF-induced activation of the Janus kinase (JAK)/signal transducers and activators of transcription (STAT) pathway. Activation of the JAK/STAT pathway has previously been shown to be dependent upon cytokines and is implicated in a large number of inflammatory diseases.
Learning how not to be afraid
Why do some people have the ability to remain calm and relaxed even in the most stressful situations? New experiments in mice by Howard Hughes Medical Institute (HHMI) researchers are providing insight into how the brain changes when the animals learn to feel safe and secure in situations that would normally make them anxious.
Surgical technique halts cell loss, Parkinson's researchers find
Deep brain stimulation, a surgical technique often viewed as a last resort for people with Parkinson's disease, halts the progression of dopamine-cell loss in animal models, according to preliminary research by scientists at the Neuroscience Institute at the University of Cincinnati (UC) and University Hospital.

News discussion:

Medicine & Health news